31 August 2020

The efficacy and safety of about half of all drugs prescribed to children has not been adequately researched. Because growth and development change the way a child's body deals with drugs, it runs an increased risk of receiving ineffective or unsafe drugs. Although many children need medication, the optimal dosage is often not known.

The Department of Pharmacology and Toxicology of the Radboudumc has started further research into more effective and safer drug doses for children, with the help of a grant from the Bill & Melinda Gates Foundation. Under the leadership of Saskia de Wildt and together with the Kinderformularium, predictive models or 'virtual children' will be used to determine the optimal dosage for children of different ages.

To ensure that children throughout Europe receive these optimized doses, the doses will be made available to doctors and pharmacists via the Kinderformularium and internationally affiliated websites. Doctors and pharmacists will be trained to use these 'virtual' children and to include dosage recommendations in the guidelines for the treatment of children. 

Related news items


Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more

Radboudumc does large-scale research on systemic sclerosis

10 September 2020

In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.

read more

Can a change in lifestyle relieve heart cramps?

10 September 2020

Cardiac spasm, or angina pectoris, is a common heart condition. Even though these patients are well monitored and treated, they are still at risk of more severe heart failure.

read more

Transfer of new anti-hepatitis C drugs across the human placenta

9 September 2020

In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time.

read more

The patient's need for medication information and its perceived quality

3 September 2020

In the International Journal of Clinical Pharmacy Charlotte Bekker showed that patients often face unmet medication information needs and that the quality of the provided information, including accessibility, comprehensiveness, reliability and understandability, is perceived as insufficient.

read more